Stay updated with breaking news from Published March. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
In this episode, hosts celebrate the 10-year anniversary of the approval of the first SGLT2 inhibitor, discuss announcements related to insulin pricing, and take a deep dive into 24-week data from the MOMENTUM trial.
The approval, which is for 4 mg naloxone hydrochloride nasal spray, marks the first OTC, nonprescription approval for a naloxone nasal spray and allows the product to be sold directly to consumers in a variety of retail locations well as online.
Tremfya demonstrated greater treatment persistence than interleukin-17 inhibitors in patients with moderate to severe plaque psoriasis and achieved clinical efficacy in scalp psoriasis, according to data presented here.Tremfya (guselkumab, Janssen Biotech) is the first and only fully human selective interleukin (IL)-23 approved in the United States for adults with moderate to severe plaque
An early rhythm control strategy for treatment of atrial fibrillation was cost-effective in a German population, according to new data from the EAST-AFNET 4 trial.“The health benefit of early rhythm control is evident. However, the cost-effectiveness of the new treatment strategy has not been evaluated so far,” Sophie Gottschalk, MSc, research fellow and PhD student in the department
On Tuesday, February 28, 2023, The University of Louisiana Monroe’s TRIO Programs Student Support Services (TRIO-SSS) visited Jackson State University in Jackson, Miss. for a graduate school tour and information session. During the visit, TRIO-SSS participants gained insight of the graduate school admissions process, funding opportunities, and met with faculty from various graduate programs of interest including Public Policy and Administration, Biology, Criminology and Justice Services, Clinical Mental Health, History, and Social Work.